Chantix, Smoking-Cessation Drug, Raises Suicide Risks, New Study Shows | WHAT REALLY HAPPENED


Chantix, Smoking-Cessation Drug, Raises Suicide Risks, New Study Shows

Pfizer's smoking cessation drug Chantix carries too many risks and should only be tried when other treatments fail, researchers said on Wednesday.

Chantix was eight times more likely to be linked with a reported case of suicidal behavior or depression than other nicotine replacement products, such as the nicotine patch, they said.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA